CorMedix Inc. financial data

Symbol
CRMD on Nasdaq
Industry
Pharmaceutical Preparations
Location
300 Connell Drive, Suite 4200, Berkeley Heights, NJ
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 718 % -27.1%
Quick Ratio 1.38 % -38.6%
Debt-to-equity 16.2 % +33.4%
Return On Equity -82.5 % -19.8%
Return On Assets -71 % -15.6%
Operating Margin -46.8K % -204%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.9M shares +1.92%
Common Stock, Shares, Outstanding 55.3M shares +20.7%
Entity Public Float 180M USD +9.82%
Common Stock, Value, Issued 55.3K USD +20.7%
Weighted Average Number of Shares Outstanding, Basic 57.6M shares +27%
Weighted Average Number of Shares Outstanding, Diluted 57.6M shares +27%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 806K USD
Cost of Revenue 510K USD
Research and Development Expense 6.44M USD -51.9%
Selling and Marketing Expense 7.39M USD +127%
General and Administrative Expense 7.56M USD +101%
Operating Income (Loss) -58.1M USD -52.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.2M USD -25.5%
Income Tax Expense (Benefit) -1.39M USD
Net Income (Loss) Attributable to Parent -53.1M USD -43.9%
Earnings Per Share, Basic -0.92 USD/shares -6.98%
Earnings Per Share, Diluted -0.92 USD/shares -6.98%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.5M USD +44.9%
Accounts Receivable, after Allowance for Credit Loss, Current 206K USD
Inventory, Net 4.01M USD
Assets, Current 53.2M USD -2.62%
Property, Plant and Equipment, Net 1.92M USD +20%
Operating Lease, Right-of-Use Asset 568K USD -19.9%
Assets 57.7M USD +1.22%
Accounts Payable, Current 3.34M USD +15.3%
Employee-related Liabilities, Current 1.79M USD +24.8%
Accrued Liabilities, Current 7.61M USD +75.1%
Liabilities, Current 11.1M USD +50.4%
Operating Lease, Liability, Noncurrent 435K USD -26.8%
Liabilities 11.5M USD +44.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 85.7K USD -5.48%
Retained Earnings (Accumulated Deficit) -350M USD -17.9%
Stockholders' Equity Attributable to Parent 46.2M USD -5.85%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 53.9M USD -9.92%
Liabilities and Equity 57.7M USD +1.22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.3M USD -66.5%
Net Cash Provided by (Used in) Financing Activities -97.1K USD -101%
Net Cash Provided by (Used in) Investing Activities 8.94M USD
Common Stock, Shares Authorized 160M shares 0%
Common Stock, Shares, Issued 55.3M shares +20.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.46M USD +52.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28.6M USD +44%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9.84K USD +12.1%
Deferred Tax Assets, Valuation Allowance 70.8M USD +22.5%
Deferred Tax Assets, Gross 70.8M USD +22.5%
Operating Lease, Liability 594K USD -19.4%
Depreciation 21.8K USD +29.4%
Payments to Acquire Property, Plant, and Equipment 61.3K USD +315%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -53.1M USD -44.1%
Lessee, Operating Lease, Liability, to be Paid 690K USD
Property, Plant and Equipment, Gross 1.87M USD +15.9%
Operating Lease, Liability, Current 159K USD +11.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 211K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 208K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 96K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 169K USD
Preferred Stock, Shares Issued 182K shares 0%
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 169K USD
Operating Lease, Payments 203K USD +2%
Additional Paid in Capital 396M USD +14.5%
Preferred Stock, Shares Outstanding 182K shares 0%
Share-based Payment Arrangement, Expense 68K USD +36%
Interest Expense 36.1K USD +12.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%